anne wojcicki regeneron

News

23andMe, Anne Wojcicki and Regeneron

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer

Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday. WHY IT

CNBC on MSN · 3d

Former 23andMe CEO Anne Wojcicki wins bid for control of her former company, topping Regeneron

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.

Fox Business on MSN · 2d

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm

Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...

2don MSN

Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

1don MSN

Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results